24-Aug-2026
Pfizer Stock (PFE) Is a Buy despite Declining Revenues
TipRanks (Mon, 24-Aug 8:18 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Mon, 24-Aug 7:30 AM ET)
SA Asks: What are the most promising oncology companies right now?
Seeking Alpha News (Sat, 22-Aug 5:57 PM ET)
Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside
TipRanks (Sat, 22-Aug 11:02 AM ET)
HHS seeking public input on vaccine recommendation categories
Seeking Alpha News (Fri, 21-Aug 2:21 PM ET)
Pfizer’s India Migraine Study Adds Real-World Momentum for PFE
TipRanks (Fri, 21-Aug 12:32 PM ET)
Pfizer’s Atirmociclib Liver Study Adds Fresh Momentum to PFE’s Pipeline
TipRanks (Fri, 21-Aug 12:32 PM ET)
Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies
TipRanks (Fri, 21-Aug 12:31 PM ET)
Pfizer Advances PF-07248144 With Key Drug-Interaction Study Completion
TipRanks (Fri, 21-Aug 12:31 PM ET)
Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress
TipRanks (Fri, 21-Aug 12:30 PM ET)
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Pfizer trades on the NYSE stock market under the symbol PFE.
As of August 24, 2026, PFE stock price declined to $27.97 with 17,228,328 million shares trading.
PFE has a beta of 0.42, meaning it tends to be less sensitive to market movements. PFE has a correlation of 0.04 to the broad based SPY ETF.
PFE has a market cap of $159.02 billion. This is considered a Large Cap stock.
Last quarter Pfizer reported $15 billion in Revenue and $.77 earnings per share. This beat revenue expectation by $608 million and exceeded earnings estimates by $.09.
In the last 3 years, PFE traded as high as $37.15 and as low as $20.92.
The top ETF exchange traded funds that PFE belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
PFE has underperformed the market in the last year with a return of +15.3%, while SPY returned +21.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PFE shares. However, PFE has outperformed the market in the last 3 month and 2 week periods, returning +9.4% and +4.5%, while SPY returned +3.1% and -1.3%, respectively. This indicates PFE has been having a stronger performance recently.
PFE support price is $27.68 and resistance is $28.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PFE shares will trade within this expected range on the day.